NodThera raises $55m in Series B round to trial inflammatory...

The Anglo-US biotech NodThera has raised $55 million in a second financing round as it prepares its inflammatory diseases drugs for clinical trials. 

California's AMT is latest biotech aiming to go public in pa...

California’s Applied Molecular Transport has become the latest biotech to go for an IPO during the pandemic, aiming to raise $100 million to take an oral ulcerative colitis drug into phase

3rd Annual Bioprocessing Summit Europe

Final Weeks to Register for Premier Bioprocessing Event

Can we target coronavirus RNA with siRNA drugs?

NEW: RNAi-Based Therapeutics Summit

Is Neil Woodford planning an audacious comeback?

Prescient hires senior members to Advisory

PRESCIENT ADVISORY ANNOUNCES RECENT APPOINTMENTS